PDCD1 and colorectal carcinoma: Our findings suggest that SRE would not only have a cytotoxic effect on CRC cells but also promote T cell immunity and have anticancer effects via inhibition of PD-1/PD-L1 interaction in splenocyte-tumor coculture systems.